Harlan CRS Cytotest Cell Research joins EU-NETVAL
Will contribute to the development of guidance documents, training materials and tools that facilitate alternatives to animal testing
Harlan Contract Research Services’ (CRS) Cytotest Cell Research in Rossdorf, Germany, has been named one of the first laboratories to be included in the European Union Network of Laboratories for the Validation of Alternative Methods (EU-NETVAL).
EU-NETVAL provides support for the European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) to develop methods to reduce, refine or replace animals used for scientific purposes.
‘Being in the initial group of laboratories acknowledges the expertise of our scientists as well as our continuous work in and support for alternative in vitro methodologies, including our participation in EU validation projects in the past,’ said Albrecht Poth, Deputy Managing Director and scientific advisor for Harlan CRS Cytotest Cell Research.
The EURL ECVAM aims to promote the scientific and regulatory acceptance of non-animal tests and to coordinate the independent evaluation of tests for specific purposes. Harlan CRS Cytotest Cell Research will contribute to the development of guidance documents, procedures, training materials and collaboration tools that facilitate the development, validation and acceptance of alternative methods.
‘We have been researching new test systems in the fields of alternative toxicology, medical devices and genetic toxicology for several years,’ said Poth. ‘Our hope is that someday we can eliminate animal testing entirely.’
